KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Finished Goods: 2010-2012

Historic Finished Goods for Jazz Pharmaceuticals (JAZZ) over the last 1 years, with Sep 2012 value amounting to $22.2 million.

  • Jazz Pharmaceuticals' Finished Goods was N/A to $22.2 million in Q3 2012 from the same period last year, while for Sep 2012 it was $22.2 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2011, which is 6.86% up from last year.
  • According to the latest figures from Q3 2012, Jazz Pharmaceuticals' Finished Goods is $22.2 million, which was down 41.79% from $38.2 million recorded in Q2 2012.
  • In the past 5 years, Jazz Pharmaceuticals' Finished Goods ranged from a high of $38.2 million in Q2 2012 and a low of $1.4 million during Q4 2010.
  • Its 3-year average for Finished Goods is $15.2 million, with a median of $12.6 million in 2012.
  • Data for Jazz Pharmaceuticals' Finished Goods shows a peak YoY grew of 6.86% (in 2011) over the last 5 years.
  • Over the past 3 years, Jazz Pharmaceuticals' Finished Goods (Quarterly) stood at $1.4 million in 2010, then grew by 6.86% to $1.4 million in 2011, then reached $22.2 million in 2012.
  • Its Finished Goods was $22.2 million in Q3 2012, compared to $38.2 million in Q2 2012 and $12.6 million in Q1 2012.